# DANYELZA
> **BLA761171** · Biologics License Application · Sponsor: Y-MABS THERAPEUTICS INC · Approved 2020-11-25
## Drug
- **FDA Application Number:** BLA761171
- **Application type:** Biologics License Application
- **Brand name:** DANYELZA
- **Generic name:** NAXITAMAB
- **Active ingredients:** NAXITAMAB-GQGK
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** Y-MABS THERAPEUTICS INC
- **Manufacturer:** Y-mAbs Therapeutics, Inc.
- **First approval:** 2020-11-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761171)
---
*AI Analytics · CC0 1.0*